ThromboGenics

Quick facts

Phase 3 pipeline

• Ocriplasmin 125µg · Ophthalmology
  Ocriplasmin is a recombinant microplasmin that enzymatically cleaves fibronectin and laminin in the vitreous to dissolve vitreous-retinal adhesions.

Phase 2 pipeline

• Ocriplasmin 25µg
• Ocriplasmin 75µg

Phase 1 pipeline

• THR-687 dose level 3

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• ThromboGenics portfolio CI brief
• ThromboGenics pipeline updates RSS